Total Payments
$11,440
2024 Payments
$1,633
Companies
38
Transactions
655
Medicare Patients
31,039
Medicare Billing
$5.1M
Payment Breakdown by Category
Food & Beverage$11,070 (96.8%)
Education$369.83 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,070 | 646 | 96.8% |
| Education | $369.83 | 9 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,060 | 100 | $0 (2024) |
| Janssen Biotech, Inc. | $1,609 | 104 | $0 (2023) |
| Amgen Inc. | $1,437 | 78 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $807.21 | 73 | $0 (2024) |
| PFIZER INC. | $789.73 | 54 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $742.93 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $447.25 | 22 | $0 (2024) |
| UCB, Inc. | $434.50 | 21 | $0 (2024) |
| Radius Health, Inc. | $372.89 | 21 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $361.39 | 18 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,633 | 82 | ABBVIE INC. ($454.05) |
| 2023 | $1,500 | 70 | AbbVie Inc. ($469.35) |
| 2022 | $1,734 | 86 | Janssen Biotech, Inc. ($458.87) |
| 2021 | $1,055 | 56 | AbbVie Inc. ($308.30) |
| 2020 | $358.16 | 20 | PFIZER INC. ($71.83) |
| 2019 | $1,804 | 114 | E.R. Squibb & Sons, L.L.C. ($221.83) |
| 2018 | $1,773 | 119 | Janssen Biotech, Inc. ($291.17) |
| 2017 | $1,582 | 108 | Amgen Inc. ($215.76) |
All Payment Transactions
655 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $24.22 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $14.62 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $0.58 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Bone Health | ||||||
| 10/17/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Immunology | ||||||
| 10/11/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/11/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $34.19 | General |
| Category: Not Applicable | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Bone Health | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $20.97 | General |
| Category: Immunology | ||||||
| 09/13/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 7,403 | 88,567 | $2.5M | $1.2M |
| 2022 | 45 | 7,405 | 61,119 | $2.1M | $1.1M |
| 2021 | 48 | 7,765 | 71,014 | $2.3M | $1.2M |
| 2020 | 47 | 8,466 | 95,458 | $2.6M | $1.5M |
Total Patients
31,039
Total Services
316,158
Medicare Billing
$5.1M
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 380 | 25,440 | $636,000 | $467,428 | 73.5% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 58 | 22,890 | $343,350 | $181,879 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 586 | 1,176 | $318,602 | $114,641 | 36.0% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 13 | 3,200 | $192,000 | $108,000 | 56.2% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 12 | 7,450 | $238,400 | $78,775 | 33.0% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 13 | 18,800 | $188,000 | $73,339 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 531 | 794 | $151,670 | $55,652 | 36.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 455 | 784 | $113,559 | $46,024 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 197 | 197 | $69,699 | $25,282 | 36.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 572 | 784 | $57,310 | $22,744 | 39.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 35 | 113 | $23,165 | $11,213 | 48.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 749 | 1,265 | $12,174 | $10,326 | 84.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 395 | 630 | $12,083 | $4,794 | 39.7% |
| 82310 | Calcium level, total | Office | 2023 | 601 | 915 | $10,644 | $4,630 | 43.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $12,623 | $4,444 | 35.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 107 | 107 | $8,423 | $4,153 | 49.3% |
| 84080 | Phosphatase (enzyme) measurement, alkaline, isoenzymes | Office | 2023 | 252 | 277 | $8,310 | $4,011 | 48.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 82 | 84 | $8,561 | $3,398 | 39.7% |
| 82565 | Blood creatinine level | Office | 2023 | 389 | 629 | $7,192 | $3,158 | 43.9% |
| 80076 | Liver function blood test panel | Office | 2023 | 190 | 303 | $6,115 | $2,427 | 39.7% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2023 | 385 | 622 | $6,140 | $2,407 | 39.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 33 | 34 | $4,728 | $1,852 | 39.2% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 187 | 349 | $3,057 | $1,459 | 47.7% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 157 | 278 | $3,553 | $1,412 | 39.7% |
| 84100 | Phosphate level | Office | 2023 | 252 | 278 | $2,794 | $1,293 | 46.3% |
About Dr. David Alboukrek, MD
Dr. David Alboukrek, MD is a Rheumatology healthcare provider based in Delray Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255434031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Alboukrek, MD has received a total of $11,440 in payments from pharmaceutical and medical device companies, with $1,633 received in 2024. These payments were reported across 655 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($11,070).
As a Medicare-enrolled provider, Alboukrek has provided services to 31,039 Medicare beneficiaries, totaling 316,158 services with total Medicare billing of $5.1M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Delray Beach, FL
- Active Since 09/06/2006
- Last Updated 08/05/2010
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1255434031
Products in Payments
- RINVOQ (Biological) $948.89
- TREMFYA (Drug) $900.42
- ORENCIA (Biological) $807.21
- XELJANZ (Drug) $643.54
- EVENITY (Biological) $614.13
- COSENTYX (Biological) $609.80
- SIMPONI ARIA (Biological) $525.54
- ACTHAR (Biological) $499.61
- Humira (Biological) $490.25
- BENLYSTA (Biological) $447.25
- Enbrel (Biological) $442.94
- Cimzia (Drug) $434.50
- KRYSTEXXA (Biological) $267.79
- Prolia (Biological) $266.17
- HUMIRA (Biological) $249.99
- SKYRIZI (Biological) $247.79
- Tymlos (Drug) $188.77
- Tymlos (Biological) $184.12
- KEVZARA (Drug) $163.90
- TERIPARATIDE (Drug) $145.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Delray Beach
Shawn Baca, Md, MD
Rheumatology — Payments: $27,459
Rheumatology $27,459
Dr. Philippe Saxe, M.d, M.D
Rheumatology — Payments: $21,041
Rheumatology $21,041
Dr. Marypat Clements, D.o, D.O
Rheumatology — Payments: $18,452
Rheumatology $18,452
Dr. Steven Goodman, M.d, M.D
Rheumatology — Payments: $18,367
Rheumatology $18,367
William Romanos, Md, MD
Rheumatology — Payments: $12,343
Rheumatology $12,343
Dr. Shelley Singh, D.o, D.O
Rheumatology — Payments: $11,578
Rheumatology $11,578